Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Metformin M/R tablets |
2nd line - only for patients intolerant of slowly titrated standard release metformin. Sukkarto SR 500mg and 1000mg. |
|
|
|
Metformin tablets | ||
|
|
Methylprednisolone acetate | ||
|
|
Methylprednisolone acetate injection | ||
|
|
Methylprednisolone/lidocaine injection | ||
|
|
Metoclopramide injections |
Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects |
|
|
|
Metoclopramide suspension |
Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects |
|
|
|
Metoclopramide tablets |
Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects |
|
|
|
Metoclopramide tablets#4.6 | ||
|
|
Metoprolol M/R tablets |
